Inspire Medical Systems, Inc. to Participate in the Wells Fargo 2025 MedTech Innovation Spotlight
MINNEAPOLIS, May 30, 2025 (GLOBE NEWSWIRE) -- Inspire Medical Systems, Inc. (NYSE: INSP) (Inspire), a medical technology company focused on the development and commercialization of innovative, minimally invasive solutions for patients with obstructive sleep apnea, announced today that its management team will participate in the Wells Fargo 2025 MedTech Innovation Spotlight on Friday, June 13, 2025.
Inspire is scheduled to present at 12:00 p.m. Eastern Time. The presentation will be accessible via a live webcast here.
A webcast replay of the presentation will be available for two weeks following the presentation in the Event Archive section of Inspire's Investor website at https://investors.inspiresleep.com.
About Inspire Medical SystemsInspire is a medical technology company focused on the development and commercialization of innovative, minimally invasive solutions for patients with obstructive sleep apnea. Inspire's proprietary Inspire therapy is the first and only FDA, EU MDR, and PDMA-approved neurostimulation technology that provides a safe and effective treatment for moderate to severe obstructive sleep apnea.
For additional information about Inspire, please visit www.inspiresleep.com.
Investor and Media ContactEzgi YagciVice President, Investor Relationsezgiyagci@inspiresleep.com617-549-2443Sign in to access your portfolio
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
San Francisco Chronicle
40 minutes ago
- San Francisco Chronicle
FDA approves Moderna's new lower-dose COVID-19 vaccine
The U.S. approved a new COVID-19 vaccine made by Moderna late Friday but with limits on who can use it — not a replacement for the company's existing shot, but a second option. The new vaccine, mNexspike, is a step toward next-generation coronavirus vaccines. It's made in a way that allows for a lower dose — a fifth of the dose of its current COVID-19 vaccine, Spikevax — by refining its immune target. The approval 'adds an important new tool to help protect people at high risk of severe disease from COVID-19,' Stephane Bancel, Moderna's CEO, said in a statement Saturday. The Food and Drug Administration approved the new vaccine for use in all adults 65 and older, and for people age 12 to 64 who have a least one health condition that puts them at increased risk from the coronavirus. That's the same limit that the FDA set in licensing another COVID-19 vaccine option from competitor Novavax. Those restrictions are a departure from how the U.S. has handled COVID-19 vaccines until now, reflecting skepticism about vaccines from Health Secretary Robert F. Kennedy Jr. and other Trump officials. Moderna's existing vaccine doesn't face those limits and has long been used for anyone ages 6 months and older. The company said it expected to offer both options this fall. The FDA's approval was based on a study of 11,400 people age 12 and older that compared the new low-dose vaccine with Moderna's existing vaccine. It found the new vaccine was safe and was at least as effective — and more by some measures — than the original shot, the company said. The news came just days after the Trump administration canceled funding for Moderna to develop a vaccine against potential pandemic flu viruses, including the H5N1 bird flu, despite promising early study results. ___ The Associated Press Health and Science Department receives support from the Howard Hughes Medical Institute's Science and Educational Media Group and the Robert Wood Johnson Foundation. The AP is solely responsible for all content.
Business Upturn
44 minutes ago
- Business Upturn
Dignity Made Launches to Fight Trafficking with Ethical Coconut Oil
St. Paul, MN, May 31, 2025 (GLOBE NEWSWIRE) — Dignity Coconuts, known for its premium, ethically sourced coconut oil, has rebranded as Dignity Made, a powerful new identity that puts its social mission front and center. More than a name change, the launch of Dignity Made signals a bold step forward in using business as a force to prevent human trafficking and empower coconut farmers in rural areas of the Philippines. Rooted in the belief that ethical jobs can prevent exploitation, Dignity Made partners directly with coconut farming communities in the Philippines to provide dignified work, education, and economic opportunity- especially for women vulnerable to trafficking. With each product sold, the brand fuels real solutions to generational poverty and systemic injustice. 'We're not just making coconut oil. We're creating a path out of poverty, one jar at a time,' said Erik Olson, CEO of Dignity Made. 'Our rebrand reflects who we've truly been all along: a company committed to making better products and a better world.' Same Mission, Bigger Vision Originally founded in 2010 as Dignity Coconuts, the company has earned awards for its raw, centrifuge-extracted coconut oil and transparent sourcing model. Now, with a growing lineup of clean beauty and wellness products, the Dignity Made name reflects a broader commitment to both consumers and the communities behind each product. With the tagline 'Better for You, Better for All,' Dignity Made continues its pledge to offer clean, safe products while empowering the people who make them through fair trade, safe jobs, and skills-based employment. Real Impact Where It Matters To date, the company has helped over 200 families rise above subsistence living. Through on-the-ground programs in financial literacy, education, and job creation, Dignity Made is breaking cycles of dependency and trafficking vulnerability—replacing them with dignity, purpose, and hope. 'I used to feel hopeless,' says Angeline, one of the women employed through Dignity Made. 'Now my child is in school, I have peace at home, and I'm always smiling. I can't explain the joy—it's spreading through our whole community.' As a verified member of the Fair Trade Federation, Dignity Made adheres to the highest standards of ethical production and environmental stewardship, including a goal to have zero-waste coconut processing that maximizes every part of the crop. To learn more or explore Dignity Made's product line, visit About Dignity Made Dignity Made is a purpose-driven social enterprise committed to fighting poverty and human trafficking through clean, coconut-based products. By building direct trade partnerships with Filipino farmers and investing in community transformation, Dignity Made goes beyond commerce to create lasting change. Every product supports ethical labor, environmental responsibility, and the belief that everyone deserves the chance to live free from exploitation. Disclaimer: The above press release comes to you under an arrangement with GlobeNewswire. Business Upturn takes no editorial responsibility for the same.
Business Upturn
44 minutes ago
- Business Upturn
AI Meets XRPL: Nimanode's $NMA Presale Gains Momentum as AI Agents Set to Transform Web3 Automation
By GlobeNewswire Published on May 31, 2025, 21:12 IST LEEDS, United Kingdom, May 31, 2025 (GLOBE NEWSWIRE) — Nimanode, the trailblazing AI-powered platform built on the XRP Ledger, has officially launched its $NMA token presale, which started on May 22, 2025 and will remain live for a 30-day window. As XRP continues to gain momentum, boosted by renewed institutional inflows and its recent recognition as a cornerstone asset in the U.S. Strategic Crypto Reserve — projects like Nimanode are emerging at the forefront of XRPL's next evolution, combining zero-code AI automation with real on-chain utility. JOIN $NMA PRESALE Nimanode is positioning itself at the intersection of artificial intelligence and decentralized technology. While much of the Web3 space remains focused on static smart contracts, Nimanode introduces something radically different: autonomous AI agents that users can build, deploy, and monetize — with zero coding required. What's so Special about Nimanode? They boast of a suite of AI agents that can be deployed all from a no-code interface Web3 Customer Support Agents – Deployment AI agents 24/7 Web3-based customer support DeFi Autopilot Agent – AI Agents that not only trade but research, analyse and present optimal APY for its users Risk Assessment Agent – Designed to safeguard users by analyzing every dApp or token address a user interacts with. Why Whale's are Scooping $NMA With a deliberately limited supply of just 200 million tokens, $NMA's tokenomics are designed to reward early adopters and its ecosystem participants. Positioned at the core of Nimanode's decentralized infrastructure, the token offers holders access to staking rewards, governance participation, and revenue-sharing opportunities. Holding the $NMA Token unlocks the full potential of the ecosystem, including: Agent Deployment – Reduced fees for launching agents when holding a minimum $NMA balance Agent Marketplace – Use $NMA to access premium agents or receive exclusive discounts Staking Benefits – Stake $NMA to earn passive income through the platform's reward pool Governance Access – Participate in protocol decisions and vote on proposals that shape Nimanode's future Buy $NMA Token How To Join The Nimanode Presale Here's how you can participate: Buy XRP from reputable exchanges like Binance, Coinbase, or Bybit Send them to an XRP Compatible Wallet (Xaman recommended) to hold your purchased XRP. Go to Nimanode's presale page , copy the deposit address, and send your XRP to it. Receive your tokens via airdrop 24 hours after the presale concludes. Act Now, Don't Miss Out The market is heating up. BTC is hitting new highs. But the smartest investors aren't just riding waves, they're positioning for what powers the next one. AI isn't coming — it's already here, and Nimanode gives you the keys to deploy it. Get your $NMA while it's still early. WEBSITE | TWITTER | TELEGRAM | WHITEPAPER Contact:Nick Lambert [email protected] Disclaimer : This is a paid post and is provided by Nimanode. The statements, views, and opinions expressed in this content are solely those of the content provider and do not necessarily reflect the views of this media platform or its publisher. We do not endorse, verify, or guarantee the accuracy, completeness, or reliability of any information presented. We do not guarantee any claims, statements, or promises made in this article. This content is for informational purposes only and should not be considered financial, investment, or trading advice. Investing in crypto and mining-related opportunities involves significant risks, including the potential loss of capital. It is possible to lose all your capital. These products may not be suitable for everyone, and you should ensure that you understand the risks involved. Seek independent advice if necessary. Speculate only with funds that you can afford to lose. Readers are strongly encouraged to conduct their own research and consult with a qualified financial advisor before making any investment decisions. However, due to the inherently speculative nature of the blockchain sector—including cryptocurrency, NFTs, and mining—complete accuracy cannot always be guaranteed. Neither the media platform nor the publisher shall be held responsible for any fraudulent activities, misrepresentations, or financial losses arising from the content of this press release. In the event of any legal claims or charges against this article, we accept no liability or responsibility. Globenewswire does not endorse any content on this page. Legal Disclaimer: This media platform provides the content of this article on an 'as-is' basis, without any warranties or representations of any kind, express or implied. We assume no responsibility for any inaccuracies, errors, or omissions. We do not assume any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information presented herein. Any concerns, complaints, or copyright issues related to this article should be directed to the content provider mentioned above. A photo accompanying this announcement is available at Disclaimer: The above press release comes to you under an arrangement with GlobeNewswire. Business Upturn takes no editorial responsibility for the same. GlobeNewswire provides press release distribution services globally, with substantial operations in North America and Europe.
